Target
Transcription initiation factor TFIID subunit 1 [1504-1635]
Ligand
BDBM346502
Substrate
n/a
Meas. Tech.
AF1-BD2 TR-FRET Binding Assay
IC50
37.2±n/a nM
Citation
 Adler, MBurdick, DJCrawford, TDuplessis, MMagnuson, SRNasveschuk, CGRomero, FATang, YTsui, VHWang, S Therapeutic compounds and uses thereof US Patent  US10202378 Publication Date 2/12/2019 
Target
Name:
Transcription initiation factor TFIID subunit 1 [1504-1635]
Synonyms:
BA2R | CCG1 | CCGS | TAF1 | TAF1-BD2 (11 1504-1635) | TAF1-BD2 (aa 1504-1635) | TAF1_HUMAN | TAF2A
Type:
Enzyme Catalytic Domain
Mol. Mass.:
15296.09
Organism:
Homo sapiens (Human)
Description:
P21675[1504-1635]
Residue:
132
Sequence:
QVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDLETIRKNISKHKYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIVNVCYQTLTEYDEHLTQLEKDICTAKEAALEEAELESLD
  
Inhibitor
Name:
BDBM346502
Synonyms:
US10202378, Example 106 | [3-(hydroxymethyl)phenyl]methyl4-(3-cyclopropyl-3-hydroxy-but-1-ynyl)-2,6-dimethyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-3-carboxylate
Type:
Small organic molecule
Emp. Form.:
C25H26N2O5
Mol. Mass.:
434.4843
SMILES:
Cc1[nH]c2c(c1C(=O)OCc1cccc(CO)c1)c(cn(C)c2=O)C#CC(C)(O)C1CC1
Structure:
Search PDB for entries with ligand similarity: